表紙
市場調查報告書
商品編碼
1084467

全球早洩治療市場預測(2022-2028)

Premature Ejaculation Treatment Market - Global Forecast, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 190 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球早洩治療市場正受到新產品推出的增加、不健康的生活方式和憂鬱症等各種因素導致的早洩增加以及荷爾蒙失調的推動。

本報告按市場概況、市場規模和預測、趨勢、增長因素、抑制因素、藥物類型、給藥途徑、劑型、分銷渠道和地區對全球早洩治療市場進行了調查條件等等。

目錄

第 1 章調查目標/先決條件

    • 調查目的
    • 假設
    • 縮寫

第 2 章市場展望

    • 報告說明
    • 市場定義和範圍
    • 執行摘要
    • 市場細分:按藥物類型
    • 市場細分:按管理途徑
    • 市場細分:按劑型
    • 市場細分:按分銷渠道
    • 市場細分:按地區
    • 連貫的機會圖 (COM)

第 3 章市場動態、監管和趨勢分析

    • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • PEST 分析
    • 管道分析
    • 產品認證
    • 產品發布
    • 協作-收購
    • 波特五力分析

第 4 章全球早洩治療市場:按藥物類型(2017-2028 年)

    • 簡介
    • 市場份額分析(2022 年和 2028 年)
    • 同比增長分析(2017-2028)
    • 細分趨勢
    • 選擇性血清素再攝取抑製劑 (SSRI)
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)
    • 細分趨勢
    • 達泊西汀
    • 其他
    • 5 型磷酸二酯□ (PDE5) 抑製劑
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)
    • 細分趨勢
    • 澤爾坦
    • 其他
    • 局部麻醉劑
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)
    • 其他
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)

第 5 章全球早洩治療市場:按管理途徑 (2017-2028)

    • 簡介
    • 市場份額分析(2022 年和 2028 年)
    • 同比增長分析(2017-2028)
    • 細分趨勢
    • 口服
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)
    • 本地
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)

第 6 章全球早洩治療市場:劑型 (2017-2028)

    • 簡介
    • 市場份額分析(2022 年和 2028 年)
    • 同比增長分析(2017-2028)
    • 細分趨勢
    • 片劑
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)
    • 噴霧
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)
    • 其他
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)

第 7 章全球早洩治療市場:按分銷渠道(2017-2028)

    • 簡介
    • 市場份額分析(2022 年和 2028 年)
    • 同比增長分析(2017-2028)
    • 細分趨勢
    • 醫院
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)
    • 網上藥店
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)
    • 零售藥店
    • 簡介
    • 市場規模及預測,以及同比增長率(2017-2028)

第 8 章全球早洩治療市場:按地區(2017-2028 年)

    • 簡介
    • 市場份額分析:按地區(2022 年和 2028 年)
    • 同比增長分析:按地區劃分(2017-2028)
    • 北美
    • 市場規模和預測:按藥物類型(2017-2028)
    • 市場規模和預測:按管理途徑(2017-2028)
    • 市場規模及預測:按劑型(2017-2028)
    • 市場規模和預測:按分銷渠道(2017-2028)
    • 市場規模和預測:按國家/地區分類(2017-2028)
    • 美國
    • 加拿大
    • 歐洲
    • 市場規模和預測:按藥物類型(2017-2028)
    • 市場規模和預測:按管理途徑(2017-2028)
    • 市場規模及預測:按劑型(2017-2028)
    • 市場規模和預測:按分銷渠道(2017-2028)
    • 市場規模和預測:按國家/地區分類(2017-2028)
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 市場規模和預測:按藥物類型(2017-2028)
    • 市場規模和預測:按管理途徑(2017-2028)
    • 市場規模及預測:按劑型(2017-2028)
    • 市場規模和預測:按分銷渠道(2017-2028)
    • 市場規模和預測:按國家/地區分類(2017-2028)
    • 中國
    • 印度
    • 日本
    • 東盟
    • 澳大利亞
    • 韓國
    • 其他亞太地區
    • 拉丁美洲
    • 市場規模和預測:按藥物類型(2017-2028)
    • 市場規模和預測:按管理途徑(2017-2028)
    • 市場規模及預測:按劑型(2017-2028)
    • 市場規模和預測:按分銷渠道(2017-2028)
    • 市場規模和預測:按國家/地區分類(2017-2028)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
    • 非洲
    • 市場規模和預測:按藥物類型(2017-2028)
    • 市場規模和預測:按管理途徑(2017-2028)
    • 市場規模及預測:按劑型(2017-2028)
    • 市場規模和預測:按分銷渠道(2017-2028)
    • 市場規模和預測:按國家/地區分類(2017-2028)
    • 中非
    • 南非
    • 北非
    • 中東
    • 市場規模和預測:按藥物類型(2017-2028)
    • 市場規模和預測:按管理途徑(2017-2028)
    • 市場規模及預測:按劑型(2017-2028)
    • 市場規模和預測:按分銷渠道(2017-2028)
    • 市場規模和預測:按國家/地區分類(2017-2028)
    • 海合會
    • 以色列
    • 其他中東

第 9 章競爭態勢

    • 熱圖分析
    • 公司簡介
    • Regent Pacific Group Limited
    • 公司簡介
    • 產品組合
    • 主要發展
    • 財務表現
    • 戰略
    • Menarini Group
    • 公司簡介
    • 產品組合
    • 主要發展
    • 財務表現
    • 戰略
    • Furirex Pharmaceuticals, Inc.
    • 公司簡介
    • 產品組合
    • 主要發展
    • 財務表現
    • 戰略
    • Absorption Pharmaceuticals, LLC
    • 公司簡介
    • 產品組合
    • 主要發展
    • 財務表現
    • 戰略
    • Ampio Pharmaceuticals, Inc.
    • 公司簡介
    • 產品組合
    • 主要發展
    • 財務表現
    • 戰略
    • Aytu BioScience
    • 公司簡介
    • 產品組合
    • 主要發展
    • 財務表現
    • 戰略
    • NeuroHealing Pharmaceuticals Inc.
    • 公司簡介
    • 產品組合
    • 主要發展
    • 財務表現
    • 戰略
    • Dong-A Pharmaceutical Co., Ltd.
    • 公司簡介
    • 產品組合
    • 主要發展
    • 財務表現
    • 戰略

第 10 章

    • 參考文獻
    • 調查方法
    • 關於諮詢和負責人
目錄
Product Code: CMI1956

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

Market Dynamics

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Key features of the study:

This report provides in-depth analysis of premature ejaculation treatment market and provides market size (US$ Billion) and Compound Annual Growth Rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players

It profiles leading players in the global premature ejaculation treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans

Key companies covered as a part of this study include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technological up-gradation, market expansion, and marketing tactics

The global premature ejaculation treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the premature ejaculation treatment market

Detailed Segmentation:

Global Premature Ejaculation Treatment Market, By Drug Type :

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

Global Premature Ejaculation Treatment Market, By Route of Administration:

Oral

Topical

Global Premature Ejaculation Treatment Market, By Dosage Form:

Pills

Spray

Others

Global Premature Ejaculation Treatment Market, By Distribution Channel:

Hospitals

Online Pharmacies

Retail Pharmacies

Global Premature Ejaculation Treatment Market, By Geography:

North America

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

U.S.

Canada

Europe

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

U.K.

Germany

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Latin America

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Middle East

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

GCC

Israel

Rest of Middle East

Africa

Drug Type:

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

By Route of Administration:

Oral

Topical

By Dosage Form

Pills

Spray

Others

By Distribution Channel

Hospitals

Online Pharmacies

Retail Pharmacies

By Country:

Central Africa

South Africa

North Africa

Company Profiles

Regent Pacific Group Limited *

Company Overview

Product Portfolio

Financial Performance

Key Strategies

Recent Developments

Menarini Group

Furiex Pharmaceuticals, Inc.

Absorption Pharmaceuticals, LLC

Ampio Pharmaceuticals, Inc.

Aytu BioScience

NeuroHealing Pharmaceuticals Inc.

Dong-A Pharmaceutical Co., Ltd.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Drug Type
    • Market Snippet, By Route of Administration
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • PEST Analysis
    • Pipeline Analysis
    • Product Approval
    • Product Launch
    • Collaboration-Acquisition
    • Porter's Five Forces Analysis

4. Global Premature Ejaculation Treatment Market, By Drug Type, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Segment Trends
    • Dapoxetine
    • Others
    • Phosphodiesterase Type 5 (PDE5) Inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Segment Trends
    • Zertane
    • Others
    • Topical Anesthetics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

5. Global Premature Ejaculation Treatment Market, By Route of Administration, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
    • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Topical
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

6. Global Premature Ejaculation Treatment Market, Dosage Form, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
    • Pills
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Spray
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

7. Global Premature Ejaculation Treatment Market, By Distribution Channel, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
    • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)
    • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Bn)

8. Global Premature Ejaculation Treatment Market, By Region, 2017 - 2028 (US$ Bn)

    • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017 - 2028
    • North America
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • U.S.
    • Canada
    • Europe
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
    • Latin America
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Africa
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • Central Africa
    • South Africa
    • North Africa
    • Middle East
    • Market Size and Forecast, By Drug Type, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Route of Administration, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Dosage Form, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028 (US$ Bn)
    • Market Size and Forecast, By Country, 2017 - 2028 (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East

9. Competitive Landscape

    • Heat Map Analysis
    • Company Profiles
    • Regent Pacific Group Limited
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Menarini Group
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Furiex Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Absorption Pharmaceuticals, LLC
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Ampio Pharmaceuticals, Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Aytu BioScience
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • NeuroHealing Pharmaceuticals Inc.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Dong-A Pharmaceutical Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

    • References
    • Research Methodology
    • About us and Sales Contact